“CIRCLE OF GOOD” APPROVED A NEW DRUG FOR CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY

“CIRCLE OF GOOD” APPROVED A NEW DRUG FOR CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY

.

Saved in:

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2024-09-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/2504
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BREAKTHROUGH IN DUCHENNE MUSCULAR DYSTROPHY TREATMENT
by: article Editorial
Published: (2022-07-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Tracking activity in Duchenne muscular dystrophy
by: Dina Mikimoto
Published: (2025-07-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

An Exoskeleton Design and Numerical Characterization for Children with Duchenne Muscular Dystrophy
by: Cristian Copilusi, et al.
Published: (2024-10-01)

Cardiorespiratory function in Duchenne and Becker muscular dystrophy
by: H A Taşdemir, et al.
Published: (1996-07-01)

Predicting the loss of ambulation in Duchenne muscular dystrophy
by: Edmar Zanoteli
Published: (2014-01-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Cardiac MRI in Duchenne and Becker Muscular Dystrophy
by: Manu Santhappan Girija, et al.
Published: (2024-10-01)

Motor assessment in patients with Duchenne muscular dystrophy
by: Gabriela Palhares Campolina Diniz, et al.
Published: (2012-06-01)

Examination of Factors Affecting the Development of Osteoporosis in Children with Duchenne Muscular Dystrophy
by: Yiğithan Güzin, et al.
Published: (2025-08-01)

Psychological aspects in children affected by Duchenne de Boulogne muscular dystrophy
by: Michele Roccella, et al.
Published: (2012-01-01)

A review of evaluation methods for Duchenne muscular dystrophy
by: Zeinab Famili, et al.
Published: (2025-06-01)

Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives
by: Paulo Victor Sgobbi de Souza, et al.

Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
by: Inga V. Anisimova, et al.
Published: (2023-11-01)

Understanding Duchenne muscular dystrophy-associated brain pathology
by: Minou A. T. Verhaeg, et al.
Published: (2025-07-01)

Computer task performance by subjects with Duchenne muscular dystrophy
by: Malheiros SR, et al.
Published: (2015-12-01)

Serum protein biomarker signature of Duchenne muscular dystrophy
by: Paul Dowling, et al.
Published: (2025-05-01)

Postural control in early stages of Duchenne muscular dystrophy
by: Cristhina Bonilha Huster Siegle, et al.
Published: (2025-06-01)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
by: Andrea Barp, et al.
Published: (2015-01-01)

Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy
by: Alexandra Prufer de Queiroz Campos Araujo, et al.
Published: (2023-01-01)

Current and emerging treatment strategies for Duchenne muscular dystrophy
by: Mah J
Published: (2016-07-01)

Therapeutic options for Duchenne muscular dystrophy: hope or hype?
by: Jean K. Mah
Published: (2025-06-01)

MRI Definition of Involved Muscle in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2011-03-01)

Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy
by: Joyce Martini, et al.
Published: (2014-01-01)

Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy
by: Thiago Henrique da SILVA, et al.
Published: (2020-02-01)

Prenatal Diagnosis of the Duchenne Muscular Dystrophy. A Family Presentation
by: Humberto Perera Navarro, et al.
Published: (2007-05-01)

Duchenne muscular dystrophy and Duane's syndrome: a rare association
by: Lívia M.A. Pasqualin, et al.
Published: (2013-02-01)

Consensus concept of modern effective therapy for Duchenne muscular dystrophy
by: T. A. Gremyakova, et al.
Published: (2023-06-01)

Phase angle as a predictor of motor function decline in children with Duchenne muscular dystrophy
by: Qin Hu, et al.
Published: (2025-07-01)

Predictors of Language and Speech Development in Boys with Duchenne Muscular Dystrophy
by: Eliška Macků, et al.
Published: (2024-12-01)

Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs
by: Dennis O. Pérez-López, et al.
Published: (2025-03-01)

Symptomatic female carriers of mutations in the Duchenne muscular dystrophy gene
by: Marcelo Maroco CRUZEIRO, et al.
Published: (2020-09-01)

Duchenne muscular dystrophy: recent insights in brain related comorbidities
by: Cyrille Vaillend, et al.
Published: (2025-02-01)

Dynamics of the course of Duchenne muscular dystrophy in patients taking ataluren and concomitant drug and non-drug therapy
by: V. M. Suslov, et al.
Published: (2024-01-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy.
by: Mayank Verma, et al.
Published: (2019-12-01)

Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO
by: Umme Sabrina Haque, et al.
Published: (2024-01-01)